It is known that a high Bax/Bcl-2 ratio in laryngeal squamous cell carcinoma is related to favorable prognosis, decreased risk of patient relapse, and higher disease-free survival [56]. This evidence concerns the gene BCL2 and laryngeal squamous cell carcinoma.